Found 394 matching trials
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck PHASE2 RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Show More Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck Cancer NA The purpose of this study is to evaluate the use of Transoral Robotic Surge...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) PHASE1 This is a phase 1b study, which means that the purpose of the study is to e...
Show More Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Learn More & Join Trial
Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer PHASE2 RATIONALE: Giving fluconazole may be effective in preventing or controlling...
Show More Location
Sylvester Cancer Center, University of Miami
Learn More & Join Trial
Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer PHASE2 Investigators will determine whether a treatment paradigm of up-front neck ...
Show More Location
University of Michigan Cancer Center
Learn More & Join Trial
Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma NA The purpose of this study is to compare the effectiveness and side effects ...
Show More Location
Verspeeten Family Cancer Centre
Learn More & Join Trial
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
University of Alabama at Birmingham Comprehensive Cancer Center
Learn More & Join Trial
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression PHASE2 This is a multicenter, single-arm, phase II clinical study evaluating the e...
Show More Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
Learn More & Join Trial
MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer N/A RATIONALE: Diagnostic procedures, such as specialized types of magnetic res...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC) PHASE2 The aim of the study is to investigate the efficacy and safety of cetuximab...
Show More Location
Seoul National University Hospital
Learn More & Join Trial